Date Filer Title Filing Type Shares Traded Price Total Held
June 12, 2024 Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 -- 135,688
June 12, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,500 -- 23,430
June 12, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,500 -- 13,667
June 12, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,500 -- 37,099
June 12, 2024 Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 112,500 -- 239,166
June 12, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,500 -- 18,666
June 12, 2024 Director, Executive Chairman of Board Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 -- 328,346
June 10, 2024 Chief Financial Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
May 13, 2024 Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 112,500 -- 126,666
March 15, 2024 Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 -- 110,688
March 15, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,500 -- 19,930
March 15, 2024 CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 -- 120,950
March 15, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,500 -- 9,167
March 15, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,500 -- 33,599
March 15, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,500 -- 14,166
March 15, 2024 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,500 -- 14,166
March 15, 2024 Director, Executive Chairman of Board Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 12,500 -- 228,346
December 11, 2023 Chief Medical Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
December 7, 2023 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 -- 20,000
December 7, 2023 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 80,000 -- 80,000
March 17, 2023 Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 85,688
March 17, 2023 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,000 -- 16,430
March 17, 2023 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,000 -- 18,429
March 17, 2023 CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 95,950
March 17, 2023 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,000 -- 4,667

For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.